MedPath

University Hospital Erlangen

University Hospital Erlangen logo
🇩🇪Germany
Ownership
Private
Established
1815-01-01
Employees
5K
Market Cap
-
Website
http://www.uk-erlangen.de

Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease

Completed
Conditions
Critical Limb Ischemia
End-stage Renal Disease
Interventions
Procedure: open revascularization
Procedure: endovascular revascularization
First Posted Date
2017-09-26
Last Posted Date
2020-03-26
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
77
Registration Number
NCT03293589
Locations
🇩🇪

University Hospital, Erlangen, Bavaria, Germany

Angiosome Perfusion After Tibial Bypass

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
First Posted Date
2017-01-06
Last Posted Date
2017-01-06
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
40
Registration Number
NCT03012750

Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography

Phase 2
Completed
Conditions
Kidney Transplantation
Interventions
First Posted Date
2016-05-18
Last Posted Date
2020-05-08
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
128
Registration Number
NCT02775838
Locations
🇩🇪

University of Erlangen, Vascular Surgery, Erlangen, Germany

🇩🇪

University of Mannheim, General Surgery, Mannheim, Germany

Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD

Not Applicable
Conditions
Inflammatory Bowel Disease
Interventions
Device: Manometry
First Posted Date
2015-06-23
Last Posted Date
2016-06-30
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
40
Registration Number
NCT02478944
Locations
🇩🇪

University Hospital Erlangen Nuremberg, Erlangen, Bavaria, Germany

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Phase 3
Active, not recruiting
Conditions
Uveal Melanoma
Interventions
Biological: Autologous Dendritic Cells loaded with autologous Tumor RNA
First Posted Date
2013-11-14
Last Posted Date
2022-12-02
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
200
Registration Number
NCT01983748
Locations
🇩🇪

Dept. of Dermatology, University Hospital, Erlangen, Bayern, Germany

🇩🇪

University Hospital Department of Ophtalmology, Tübingen, Germany

🇩🇪

Städtisches Klinikum, Dessau, Germany

Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.

Conditions
Cirrhosis
First Posted Date
2013-03-08
Last Posted Date
2016-01-21
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
200
Registration Number
NCT01807013
Locations
🇩🇪

Universitätsklinikum Erlangen Nürnberg, Erlangen, Bayern, Germany

Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites

Phase 3
Completed
Conditions
Stable Angina Pectoris
Acute Coronary Syndromes
Interventions
Device: percutaneous coronary intervention
First Posted Date
2012-08-21
Last Posted Date
2015-02-04
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
304
Registration Number
NCT01669382
Locations
🇩🇪

Universitätsklinikum Gießen, Klinik für Kardiologie, Gießen, Germany

🇩🇪

Universitätsklinikum Erlangen; Medizinische Klinik 2, Erlangen, Germany

🇩🇪

Klinikum Coburg, Coburg, Germany

HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy

Phase 2
Conditions
Prostate Cancer
Interventions
Radiation: brachytherapy
First Posted Date
2011-08-04
Last Posted Date
2011-08-04
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
100
Registration Number
NCT01409876
Locations
🇩🇪

Department of Radiation Therapy University Hospital, Erlangen, Germany

Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia

Completed
Conditions
X-linked Hypohidrotic Ectodermal Dysplasia
First Posted Date
2011-03-04
Last Posted Date
2014-01-08
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
38
Registration Number
NCT01308333
Locations
🇩🇪

University Hospital Erlangen, Competence Centre for Children with Ectodermal Dysplasias, Erlangen, Bavaria, Germany

Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer

Phase 2
Conditions
Breast Cancer
Interventions
Radiation: Interstitial multicatheter brachytherapy
First Posted Date
2010-08-05
Last Posted Date
2010-08-20
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
200
Registration Number
NCT01175694
Locations
🇩🇪

Dept. of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany

© Copyright 2025. All Rights Reserved by MedPath